Advertisement

Topics

Humira Biosimilar Interchangeability: The Race Begins

15:54 EDT 30 Jul 2017 | SCRIP

Boehringer Ingelheim announcement is first public disclosure of interchangeability trial since US FDA draft guidance was released.

      

Related Stories

 

Original Article: Humira Biosimilar Interchangeability: The Race Begins

NEXT ARTICLE

More From BioPortfolio on "Humira Biosimilar Interchangeability: The Race Begins"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...